Cardiology Department, Royal Berkshire Hospital, Reading, RG1 5AN, UK.
Keble College, University of Oxford, Parks Road, Oxford OX1 3PG, UK.
Europace. 2023 Feb 16;25(2):660-666. doi: 10.1093/europace/euac205.
Industry collaboration with arrhythmia and devices research is common. However, this results in conflicts of interest (CoI) for researchers that should be disclosed. This study aimed to examine the quality of CoI disclosures in arrhythmia and devices presentations.
Recorded presentations from the Arrhythmia & Devices section of the ESC Annual Congress 2016-2020 were assessed. The number of words, conflicts, and time displayed was documented for CoI declarations. Meta-data including sponsorship by an industry partner, presenter sex, and institution were obtained.
Of 1153 presentations assessed, 999 were suitable for inclusion. CoI statements were missing from 7.2% of presentations, and 58% reported ≥1 conflict. Those with conflicts spent less time-per-word on their disclosures (median 150 ms, interquartile range [IQR] 83-273 ms) compared with those without conflicts (median 250 ms, IQR 125-375 ms). One-in-eight presentations were sponsored (12.8%, n = 128). CoI statements were more likely to be missing in sponsored presentations (14.8%, n = 19) compared with non-sponsored presentations (6.1%, n = 53), P = 0.0003. Sponsored presentations contained a greater median number of CoIs (10, IQR 6-18) compared with non-sponsored sessions (1, IQR 0-5), P < 0.0001. Time-per-word spent on COI disclosures was 50% lower in sponsored sessions (125 ms, IQR 75-231 ms) compared with non-sponsored sessions (250 ms, IQR 125-375 ms), P < 0.0001.
The majority of those presenting arrhythmia and devices research have CoIs to declare. Declarations were often missing or displayed for short periods of time. Presenters in sponsored sessions, while being more conflicted, had a lower standard of declaration suggesting a higher risk of potential bias which viewers had insufficient opportunity to assess.
行业与心律失常和器械研究合作很常见。然而,这会导致研究人员产生利益冲突(COI),这些冲突应予以披露。本研究旨在检查心律失常和器械研究报告中 COI 披露的质量。
评估了 2016 年至 2020 年 ESC 年会心律失常和器械部分的记录报告。记录了 COI 声明的字数、冲突数量和显示时间。获取了包括行业合作伙伴赞助、演讲者性别和机构在内的元数据。
在评估的 1153 个报告中,有 999 个适合纳入。7.2%的报告未报告 COI 声明,58%的报告报告了≥1 个冲突。有冲突的报告在披露 COI 时花费的时间更少(中位数 150 毫秒,四分位距[IQR] 83-273 毫秒),而没有冲突的报告花费的时间更多(中位数 250 毫秒,IQR 125-375 毫秒)。八分之一的报告得到了赞助(12.8%,n=128)。与非赞助报告(6.1%,n=53)相比,赞助报告(14.8%,n=19)更有可能未报告 COI 声明,P=0.0003。赞助报告中 COI 的中位数数量(10,IQR 6-18)大于非赞助报告(1,IQR 0-5),P<0.0001。赞助报告中 COI 披露所用的时间更少(125 毫秒,IQR 75-231 毫秒),而非赞助报告中所用的时间更多(250 毫秒,IQR 125-375 毫秒),P<0.0001。
大多数报告心律失常和器械研究的人都有 COI 要声明。声明往往缺失或显示时间很短。在赞助报告中,虽然存在更多冲突,但披露标准较低,表明潜在偏见的风险更高,而观众则没有足够的机会进行评估。